National Stock Number (NSN) Output Data
NSN:
NIIN:
Item Name:
CLOMIPRAMINE HYDROCHLORIDE CAPSU
Definition:
Reference/Part Number
| Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
|---|---|---|---|---|---|---|---|---|
| NDC00781-2047-01 | 0THL4 | A | 5 | 2 | 4 | ZZ | ||
| ANAFRANIL | 04482 | A | 5 | 1 | 4 | KX | ||
| NDC58887-0117-30 | 04482 | A | 3 | 2 | 4 | ZZ | ||
| NDC00093-0796-01 | 80608 | A | 5 | 9 | 4 | ZZ | ||
| ANAFRANIL CAPSULES | 04482 | A | 5 | 1 | 4 | KX | ||
| NDC52544-0596-01 | 0BN85 | A | 5 | 2 | 4 | ZZ | ||
| NDC00378-3075-01 | 60895 | A | 5 | 2 | 4 | ZZ | ||
| NDC00093-0960-01 | 80608 | A | 5 | 2 | 4 | ZZ | ||
| NDC00406-9908-01 | 37940 | A | 5 | 2 | 4 | ZZ | ||
| NDC00781-2047-01 | 71115 | A | 5 | 2 | 4 | ZZ | ||
| NDC51672-4013-01 | 0MLD2 | A | 5 | 2 | 4 | ZZ |
CAGE Information
| Code | Company |
|---|---|
| 04482 | CIBA-GEIGY CORP CIBA PHARMACEUTICALS |
| 0THL4 | SANDOZ INC. |
| 80608 | LEMMON CO |
| 0BN85 | WATSON LABS INC |
| 60895 | MYLAN PHARMACEUTICALS INC |
| 37940 | MALLINCKRODT INC ANESTHESIA PRODUCTS |
| 71115 | BRISTOL-MYERS CO |
| 0MLD2 | TARO PHARMACEUTICALS USA INC |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CQLS | CAPSULE CONTENT FORM | ANY ACCEPTABLE |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CLOMIPRAMINE HYDROCHLORIDE CAPSULES 75MG 100S BT |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 75.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| AKJC | CAPSULE TYPE | ANY ACCEPTABLE |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |